September 16, 2026
1 min read

Cellares links with GenomeFrontier to test automation approach for virus-free CAR-Ts

Cellares is partnering with Taiwanese biotech GenomeFrontier Therapeutics to evaluate the integrated contract developer and manufacturer’s cell shuttle platform for use in the production of virus-free CAR-T therapies.

Leave a Reply

Your email address will not be published.

Previous Story

Banning Junk Food At Checkouts Leads To Drop In Sugar-Laden Sales, Study Finds MedNews

Next Story

Does Exercise Improve Cancer Survival? MedNews

Previous Story

Banning Junk Food At Checkouts Leads To Drop In Sugar-Laden Sales, Study Finds MedNews

Next Story

Does Exercise Improve Cancer Survival? MedNews

Latest from Blog

Go toTop